These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38264797)

  • 1. An unusual form of BRAF-V600E mutated hairy cell neoplasm with clinical resistance to BRAF inhibition: Challenging precision medicine.
    Marra A; Santi A; Pucciarini A; Venanzi A; De Carolis L; Zaja F; Ascani S; Canzonieri V; Ballanti S; Falini B; Tiacci E
    Am J Hematol; 2024 Mar; 99(3):497-501. PubMed ID: 38264797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative BRAF mutations in BRAF V600E-negative hairy cell leukaemias.
    Tschernitz S; Flossbach L; Bonengel M; Roth S; Rosenwald A; Geissinger E
    Br J Haematol; 2014 May; 165(4):529-33. PubMed ID: 24433452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hairy cell leukaemia with unusual BRAF mutations.
    Maitre E; Macro M; Troussard X
    J Cell Mol Med; 2023 Sep; 27(17):2626-2630. PubMed ID: 37530550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis using a BRAF V600E mutation specific antibody is highly sensitive and specific for the diagnosis of hairy cell leukemia.
    Wang XJ; Kim A; Li S
    Int J Clin Exp Pathol; 2014; 7(7):4323-8. PubMed ID: 25120816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia.
    Tiacci E; Schiavoni G; Martelli MP; Boveri E; Pacini R; Tabarrini A; Zibellini S; Santi A; Pettirossi V; Fortini E; Ascani S; Arcaini L; Inghirami G; Paulli M; Falini B
    Haematologica; 2013 Apr; 98(4):635-9. PubMed ID: 23349307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of V600E BRAF and D816V KIT mutations in systemic mastocytosis.
    Hägglund H; Sander B; Ahmadi A; Gülen T; Nilsson G
    Med Oncol; 2014 Aug; 31(8):123. PubMed ID: 25034364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation.
    Xi L; Arons E; Navarro W; Calvo KR; Stetler-Stevenson M; Raffeld M; Kreitman RJ
    Blood; 2012 Apr; 119(14):3330-2. PubMed ID: 22210875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF V600E Mutation Across Multiple Tumor Types: Correlation Between DNA-based Sequencing and Mutation-specific Immunohistochemistry.
    Loo E; Khalili P; Beuhler K; Siddiqi I; Vasef MA
    Appl Immunohistochem Mol Morphol; 2018; 26(10):709-713. PubMed ID: 29271794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E).
    Poulikakos PI; Persaud Y; Janakiraman M; Kong X; Ng C; Moriceau G; Shi H; Atefi M; Titz B; Gabay MT; Salton M; Dahlman KB; Tadi M; Wargo JA; Flaherty KT; Kelley MC; Misteli T; Chapman PB; Sosman JA; Graeber TG; Ribas A; Lo RS; Rosen N; Solit DB
    Nature; 2011 Nov; 480(7377):387-90. PubMed ID: 22113612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving Strategies for the Management of BRAF-Mutant Metastatic Colorectal Cancer.
    Lee HM; Morris V; Napolitano S; Kopetz S
    Oncology (Williston Park); 2019 Jun; 33(6):206-11. PubMed ID: 31219603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Secondary Mutation in
    Wang J; Yao Z; Jonsson P; Allen AN; Qin ACR; Uddin S; Dunkel IJ; Petriccione M; Manova K; Haque S; Rosenblum MK; Pisapia DJ; Rosen N; Taylor BS; Pratilas CA
    Cancer Discov; 2018 Sep; 8(9):1130-1141. PubMed ID: 29880583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis.
    Cremolini C; Di Bartolomeo M; Amatu A; Antoniotti C; Moretto R; Berenato R; Perrone F; Tamborini E; Aprile G; Lonardi S; Sartore-Bianchi A; Fontanini G; Milione M; Lauricella C; Siena S; Falcone A; de Braud F; Loupakis F; Pietrantonio F
    Ann Oncol; 2015 Oct; 26(10):2092-7. PubMed ID: 26153495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific activation of glycolytic enzyme enolase 2 in BRAF V600E-mutated colorectal cancer.
    Yukimoto R; Nishida N; Hata T; Fujino S; Ogino T; Miyoshi N; Takahashi H; Uemura M; Satoh T; Hirofumi Y; Mizushima T; Doki Y; Eguchi H
    Cancer Sci; 2021 Jul; 112(7):2884-2894. PubMed ID: 33934428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes.
    Yap J; Yuan J; Ng WH; Chen GB; Sim YRM; Goh KC; Teo J; Lim TYH; Goay SM; Teo JHJ; Lao Z; Lam P; Sabapathy K; Hu J
    Mol Cancer; 2023 Aug; 22(1):125. PubMed ID: 37543582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trametinib with or without vemurafenib in BRAF mutated non-small cell lung cancer.
    Joshi M; Rice SJ; Liu X; Miller B; Belani CP
    PLoS One; 2015; 10(2):e0118210. PubMed ID: 25706985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-label use of cetuximab plus sorafenib and panitumumab plus regorafenib to personalize therapy for a patient with V600E BRAF-mutant metastatic colon cancer.
    Al-Marrawi MY; Saroya BS; Brennan MC; Yang Z; Dykes TM; El-Deiry WS
    Cancer Biol Ther; 2013 Aug; 14(8):703-10. PubMed ID: 23792568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF(V600E) mutation influences hypoxia-inducible factor-1alpha expression levels in papillary thyroid cancer.
    Zerilli M; Zito G; Martorana A; Pitrone M; Cabibi D; Cappello F; Giordano C; Rodolico V
    Mod Pathol; 2010 Aug; 23(8):1052-60. PubMed ID: 20473281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.
    Di Nicolantonio F; Martini M; Molinari F; Sartore-Bianchi A; Arena S; Saletti P; De Dosso S; Mazzucchelli L; Frattini M; Siena S; Bardelli A
    J Clin Oncol; 2008 Dec; 26(35):5705-12. PubMed ID: 19001320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of serine 365 in BRAF V600E sensitivity to RAF inhibition.
    Vido MJ; Rock J; Aplin AE
    Pigment Cell Melanoma Res; 2021 Jul; 34(4):696-702. PubMed ID: 33000894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
    Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
    Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.